               SEQUENCE LISTING

<110> R.G.C.C. Holdings AG

<120> SARS COV-2 Vaccines

<130> F06373

<160> 6

<170> BiSSAP 1.3.6

<210> 1
<211> 9
<212> PRT
<213> Coronaviridae


<220> 
<223> SARS CoV-2 spike protein (84-92)

<400> 1
Leu Pro Phe Asn Asp Gly Val Tyr Phe 
1               5                   

<210> 2
<211> 15
<212> PRT
<213> Coronaviridae


<220> 
<223> SARS CoV-2 spike protein (326-340)

<400> 2
Ile Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu 
1               5                   10                  15  

<210> 3
<211> 9
<212> PRT
<213> Coronaviridae


<220> 
<223> SARS CoV-2 spike protein (718-726)

<400> 3
Phe Thr Ile Ser Val Thr Thr Glu Ile 
1               5                   

<210> 4
<211> 15
<212> PRT
<213> Coronaviridae


<220> 
<223> SARS CoV-2 spike protein (449-463)

<400> 4
Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro 
1               5                   10                  15  

<210> 5
<211> 9
<212> PRT
<213> Coronaviridae


<220> 
<223> SARS CoV-2 envelope protein (2-10)

<400> 5
Tyr Ser Phe Val Ser Glu Glu Thr Gly 
1               5                   

<210> 6
<211> 16
<212> PRT
<213> Coronaviridae


<220> 
<223> SARS CoV-2 spike protein (1185-1200)

<400> 6
Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu Ile Asp Leu 
1               5                   10                  15      



